Adialante

Private

Minneapolis, MinnesotaHealthcare & Life Scienceshttps://adialante.com/

Last Round

Seed

Jul 1, 2026

Total Funding Raised

$3.47M

Company Overview

Adialante is a medical device company that develops affordable, compact, and mobile MRI systems designed to make cancer screening more accessible.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

mobile MRIdiagnostic imaginghardware-as-a-servicemedical imagingMRI-as-a-serviceusage-based billingcompact MRImedical devicesimaging clinic on wheelsAI-powered imagingdiagnostic-grade imagingmagnetic resonance imagingMRIpoint-of-care imaginghealthcare analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Adialante Comps

Public and private peers based on sector, stage, and business model.

Adialante comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Adialante Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jul 1, 2026
Accelerator	Apr 23, 2026
Grant	Jun 19, 2025
Seed	Aug 30, 2024
Grant	Jun 30, 2024
Grant	Dec 1, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Parker Jenkins

Chief Operating Officer Co-Founder

Founding Team

Efraín Torres

CEO Co-Founder

Founding Team

Kyle King

Chief Financial Officer

Executive Team

Adialante Investors

Notable investors and investment history

Adialante investors
Investor	Rounds
Pioneer Fund	Accelerator
Walleye Tank	Grant
America's Seed Fund	Grant
Y Combinator	Accelerator
University of Minnesota	Seed, Grant
Fogarty Innovation	Seed, Accelerator
National Science Foundation	Seed, Grant

View all Investors

Adialante Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Adialante Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Adialante's valuation, stock price, and market status.

Firmographic Details

HeadquartersMinneapolis, Minnesota

Employee Range7

Year Founded2022

Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.